Skip to main content
. 2020 Nov 15;5(46):29755–29764. doi: 10.1021/acsomega.0c03582

Figure 5.

Figure 5

Interaction graphics between the compounds and targets: (A) PIK3CG–wogonin, (B) PIK3CG–rhamnetin, (C) PIK3CG–dauriporphine, (D) PIK3CG–chrysosplenetin B, (E) PIK3CG–5-hydroxyl-7,8-panicolin, (F) AKT1–wogonin, (G) AKT1–rhamnetin, (H) AKT1–dauriporphine, (I) AKT1–chrysosplenetin B, (J) AKT1–5-hydroxyl-7,8-panicolin, (K) PTGS2–wogonin, (L) PTGS2–rhamnetin, (M) PTGS2–dauriporphine, (N) PTGS2–chrysosplenetin B, and (O) PTGS2–5-hydroxyl-7,8-panicolin.